Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL14/YTHDC1-Mediated m6A Modification in Hippocampus Improves Pentylenetetrazol-Induced Acute Seizures. | Mol Neurobiol | 2024 | 38814536 | PubTator, text mining | PubMed |
| m6A Methylation of Transcription Leader Sequence of SARS-CoV-2 Impacts Discontinuous Transcription of Subgenomic mRNAs. | Chemistry | 2024 | 38785102 | PubTator, text mining | PubMed |
| Making Ramón y Cajal proud: Development of cell identity and diversity in the cerebral cortex. | Neuron | 2024 | 38754415 | PubTator, text mining | PubMed |
| METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer. | Cancer Biol Ther | 2024 | 38738555 | PubTator, text mining | PubMed |
| CircUGGT2 downregulation by METTL14-dependent m6A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p/MAP3K9 axis. | Pharmacol Res | 2024 | 38729588 | PubTator, text mining | PubMed |
| METTL14 regulates CD8+T-cell activation and immune responses to anti-PD-1 therapy in lung cancer. | World J Surg Oncol | 2024 | 38725005 | PubTator, text mining | PubMed |
| Increased PTCHD4 expression via m6A modification of PTCHD4 mRNA promotes senescent cell survival. | Nucleic Acids Res | 2024 | 38721764 | PubTator, text mining | PubMed |
| Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7. | Adv Sci (Weinh) | 2024 | 38696610 | PubTator, text mining | PubMed |
| Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation. | Cell Rep | 2024 | 38691450 | PubTator, text mining | PubMed |
| Unraveling the role of METTL14 in metabolic dysfunction-associated fatty liver disease: insights and therapeutic implications. | Signal Transduct Target Ther | 2024 | 38684673 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma. | Clin Exp Pharmacol Physiol | 2024 | 38679464 | PubTator, text mining | PubMed |
| Prenatal diethylhexylphthalate exposure disturbs adult Leydig cell function via epigenetic downregulation of METTL4 expression in male rats. | Ecotoxicol Environ Saf | 2024 | 38678792 | PubTator, text mining | PubMed |
| Expression patterns of m6A RNA methylation regulators under apoptotic conditions in various human cancer cell lines. | Turk J Biol | 2024 | 38665783 | PubTator, text mining | PubMed |
| CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells. | BMC Cancer | 2024 | 38664644 | PubTator, text mining | PubMed |
| [The Expression of METTL14 in Patients with Newly Diagnosed Acute Myeloid Leukemia and Its Clinical Significance]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 38660839 | PubTator, text mining | PubMed |
| METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism. | Cell Death Discov | 2024 | 38649363 | PubTator, text mining | PubMed |
| mTOR Signaling Promotes Rapid m6A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions. | Cancer Immunol Res | 2024 | 38640466 | PubTator, text mining | PubMed |
| m6A RNA Methylation and Implications for Hepatic Lipid Metabolism. | DNA Cell Biol | 2024 | 38635960 | PubTator, text mining | PubMed |
| RNA m6A modification, signals for degradation or stabilisation? | Biochem Soc Trans | 2024 | 38629637 | PubTator, text mining | PubMed |
| METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. | Signal Transduct Target Ther | 2024 | 38627387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=26